(Q54077989)
Statements
A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer. (English)
1 reference
Blagosklonny MV
1 reference
Bergan RC
1 reference
Reed E
1 reference
Myers CE
1 reference
Headlee D
1 reference
Brawley O
1 reference
Cho HK
1 reference
Figg WD
1 reference
Tompkins A
1 reference
Linehan WM
1 reference
Kohler D
1 reference
Steinberg SM
1 reference
1 September 1999
1 reference
5
1 reference
2366-2373
1 reference
9
1 reference
Identifiers
1 reference